Status:
COMPLETED
Effects of Trancutaneous Auriculotemporal Nerve Stimulation
Lead Sponsor:
University of Gran Rosario
Conditions:
Healthy
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Neuromodulation works by either actively stimulating nerves, causing the alteration or modulation of nerve activity by delivering electrical agents directly to a target area. Transcutaneous auricular...
Detailed Description
This study will be a randomized, double-blind, crossover pilot clinical trial. Its objective is to compare the immediate effects of two types of transcutaneous auriculotemporal nerve stimulation (tANS...
Eligibility Criteria
Inclusion
- Subjects of both sexes, aged 18 to 35 years;
- No symptoms or history of disease in the craniofacial region;
- No symptoms of chronic pain in any body region.
Exclusion
- History of surgery, trauma to the craniofacial region or cancer;
- Systemic disease (e.g., rheumatic disease);
- Neurological and/or psychiatric disorders;
- Altered sensation (e.g., hipo or hypersensitivity);
- Current pregnancy or menstrual cycle
- Intake medication (e.g., centrally acting);
- Prior experience with electrical stimulation treatment;
- Intense physical activity, use of stimulants and/or analgesics in the previous 24 hours;
- Acute sleep disruptions (e.g., recent sleep deprivation);
- Inability to understand the informed consent document.
Key Trial Info
Start Date :
September 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT07184190
Start Date
September 26 2025
End Date
November 14 2025
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad del Gran Rosario
Rosario, Santa Fe Province, Argentina, S2134BZH